Abstract Glucagon (GCG) like peptide1(GLP-1) has emerged as a powerful player in regulatingmetabolismanda promising therapeutic target for various chronic diseases. This review delves into the physiological roles ofGLP-1, exploring itsimpactonglucosehomeostasis, insulin secretion, and satiety. We examine the compelling evidence supportingGLP-1receptor agonists (GLP-1RAs) in ...
Jun 1, 2025This review delves into the physiological roles ofGLP-1, exploring itsimpactonglucosehomeostasis, insulin secretion, and satiety. We examine the compelling evidence supportingGLP-1receptor agonists (GLP-1RAs) in managing type 2 diabetes (T2D), obesity, and other diseases.
Aug 19, 2024In a very large study of 1,465 individuals with various degrees ofglucosetolerance, insulin resistance, obesity and T2DM, women with prediabetes or type 2 diabetes had a 25% lowerGLP-1response ...
Mar 5, 2025Glucagon-like peptide-1 receptor agonists (GLP-1RAs) have transformed obesity management, offering substantial weight loss and metabolic benefits. This review examines their expanding role, evaluating efficacy compared to alternative treatments, emerging indications, ongoing challenges, and future directions. Beyond obesity and type 2 diabetes, the therapeutic potential ofGLP-1RAs extends ...
Glucagon-like peptide1(GLP-1), a gastrointestinal peptide and central mediator ofglucosemetabolism, is secreted by L cells in the intestine in response to food intake. Postprandial secretion ofGLP-1is triggered by nutrient-sensing via transporters and G-protein-coupled receptors (GPCRs).GLP-1secretion may be lower in adults with obesity/overweight (OW) or type 2 diabetes mellitus (T2DM ...
Jun 30, 2025Glucagon-like peptide-1 (GLP-1) has emerged as a pivotal regulator in the management ofglucosehomeostasis, glycogenmetabolism,andenergybalance, positioning it as a critical therapeutic target for addressing obesity, metabolic syndrome, and type 2 diabetes mellitus (T2DM).GLP-1receptor agonists (GLP-1RAs) have shown promise for improving glycemic control and reducing weight through ...
Apr 5, 2025Beyond its hypoglycemic effect, the equally significant role ofGLP-1in obesity management.GLP-1receptors in the hypothalamus are widely expressed and play key roles in regulating appetite and food intake by enhancing satiety signals.GLP-1slows gastric emptying with prolonged postprandial satiety and modulates energybalanceby reducing overall caloric intake. Conventional weight loss ...
Sep 30, 2024Thus,GLP-1suppresses food intake through three pathways: hypothalamus, area postrema and sensory nerves1.GLP-1has a strong bloodglucose-lowering effect through pharmacologicalGLP-1actions, such as gastric emptying and appetite suppression, in addition to promoting insulin secretion and inhibiting glucagon secretion (Figure 1a).
Jan 9, 2026Discover how theGLP-1mechanism of actionimpactsglucose, appetite, heart health, liver fat, and cognitive function in clinical care.
Jun 11, 2025In healthy individuals,glucoseintake stimulates increased secretion ofGLP-1, playing a crucial role in maintainingglucosemetabolismhomeostasis. However, in rats with diet-induced obesity,GLP-1secretion in respond toglucosestimulation is significantly impaired [14].
5 days agoAs interest inGLP-1medications and metabolic health continues to grow, many people are looking for natural ways to support appetite control, blood sugarbalance,andbody composition. Inspired Nutraceuticals created GLX, a 4-in-1 completeGLP-1support system designed to target multiple pathways involved in hunger,metabolism,andgut health.
1 day agoSection 4: Metabolic Reprogramming — Changing the Body's Default State Most weight loss strategies focus on creating acaloriedeficit.GLP-1soperate on a deeper level by changing how the body processes and utilizes energy. One of the most significant effects is improved insulin sensitivity. When cells become more responsive to insulin,glucoseis more efficiently taken up and used for ...
1 day agoYour body'smetabolism, like body fat and insulin resistance, greatly affects how wellGLP-1works. Sticking to your treatment plan and making lasting lifestyle changes are also key for good results.
Premeal Metabolic Optimizer Crush cravings and reduce glycemicimpactwith nature's superfood fiber matrix. PowerBalancefuelsmetabolism, minimizing food noise and regulating appetite.Balancesblood sugar, slowing theimpactofcarbohydrates and reducing spikes & crashes* Strengthens the microbiome with diverse, prebiotic fibers, boosting gut health* How it Works PowerBalancegoes to ...
Mar 3, 2026Let me break it down for ya! Inspired introduces Glx, an InnovativeGLP-1activating formula designed to promote blood sugar control, reduce appetite, and restore healthy gut-brain -metabolismsignaling GLX 4 in1glp-1quick keys 🔹Dnf 10 peptide-weight management by acting on the gut-brain axis to reduce appetite, decreasecalorieintake, lower body fat mass, and control carb cravings ...
2 days agoUnlock the secrets ofGLP-1'srole in promoting weight loss. Explore the effects ofGLP-1receptor agonists on appetite andmetabolism.
3 days agoSustained Satiety The release of hormones like PYY andGLP-1in response to early protein intake can lead to prolonged feelings of fullness, reducing cravings and the urge to snack on less healthy options between meals. This consistent satiety is a key factor in preventing the overeating that often drives metabolic drift. Reduced Ghrelin Activity
5 days agoGLP-1s, one year later: Mayo Clinic experts discuss how these weight-loss and diabetes drugs work, changing access and costs, side effects, and what's next.
TodayCan you takeglp1with berberine? Discover the potential synergies, risks like hypoglycemia, and expert tips for combining these metabolic tools safely.
Feb 25, 2026WhileGLP-1agonists primarily work by mimicking the hormoneGLP-1to regulate appetite and insulin secretion, tirzepatide brings a second, synergistic mechanism into play with GIP. This one-two punch seems to create a more profound effect onglucosecontrol and energybalancethan targetingGLP-1alone.
Mar 7, 2026What isGLP-1? Glucagon-like peptide1(GLP-1) is a hormone produced in the intestines in response to food intake. Its primary role is to regulateglucosemetabolism. This includes managing blood sugar, regulating appetite, and supporting overall metabolic health. What is insulin resistance? Insulin is another hormone that regulates blood sugar.
4 days agoPCOS onGLP-1needs more than 80g protein. Get the exact framework: 90-120g protein, smarter carb swaps, anti-inflammatory foods, and 4 supplements that actually work.
Another critical aspect ofGLP-1therapy is itsimpactonglucosemetabolism. By enhancing insulin secretion and improving insulin sensitivity, these medications help regulate blood sugar levels, which is especially beneficial for individuals with type 2 diabetes.
ManyGLP-1users have type 2 diabetes, and creatine supplementation has shown interesting effects onglucosemetabolism. Some studies suggest creatine may improve GLUT-4 translocation (theprocess by whichglucoseenters muscle cells), potentially offering a small additional benefit for blood sugar control.
1 day ago"In general, the body takes anywhere from three to six months for itsmetabolismto find a newbalanceofwhat one consumes (calories)andwhat one expends (burns)," explains Dr. Blen Tesfu, MD, a Licensed Physician and Medical Advisor at Welzo, who regularly sees patients usingGLP-1medications in her everyday clinical work. "In general, if one continues with regular exercise (such as ...
Feb 25, 2025GLP-1plays a crucial role in liver function, particularly in regulatingglucoseproduction and lipidmetabolism. By reducingglucoseoutput and fat accumulation in the liver,GLP-1helps maintain balanced blood sugar levels and supports liver health.
5.GLP-1r Intracellular SignalingGLP-1acts in the pancreas to decrease bloodglucoseconcentrations. It achieves this by increasing the synthesis and release of insulin, in addition to increasing neogenesis, proliferation, and by decreasing apoptosis of β cells.
Nov 1, 2025DiscontinuingGLP-1RA leads to substantial long-term weight regain, ranging from 60% to 163% of prior weight loss, depending on the type ofGLP-1RA [24]. However, theimpactofearly discontinuation and subsequent weight regain on dietary behavior, including the potential for disordered eating or (micro)nutrient imbalances, remains unclear.
Jun 1, 2025Currently, three GLP-1-based agents (liraglutide, semaglutide, and tirzepatide) are approved for chronic weight management (Table). Tirzepatide, a dualGLP-1,andglucose-dependent insulinotropic polypeptide (GIP) receptor co-agonist represents an important advancement, demonstrating enhanced efficacy in weight reduction and broadening the therapeutic landscape of anti-obesity medications. As ...
Short-actingGLP-1RAs (e.g., exenatide, lixisenatide) were found to have a reducedimpactonovernight and fasting bloodglucoselevels, while long-actingGLP-1RAs (liraglutide, exenatide once weekly, dulaglutide, and semaglutide) were found to have an increased effect and better coverage on overnight and fasting bloodglucoseandHbA1c ...